Proposed Data Collection Submitted for Public Comment and Recommendations, 23358-23359 [2020-08794]
Download as PDF
23358
Federal Register / Vol. 85, No. 81 / Monday, April 27, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Traveler ...........................................................
Public Health Passenger Locator Form: Outbreak of public health significance* (international flights).
Public Health Passenger Locator Form: Limited onboard exposure † (international
flights.
Public Health Passenger Locator Form (domestic flights).
Traveler ...........................................................
Traveler ...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–08787 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–20MR; Docket No. CDC–2020–
0039]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Leptospirosis and melioidosis
active hospital-based surveillance in
Puerto Rico.’’ The project aims to
identify leptospirosis and melioidosis
cases in Puerto Rico by establishing
active surveillance for both diseases at
four hospital sites for timelier disease
identification and treatment and to
improve understanding of leptospirosis
and melioidosis epidemiology and
ecology in Puerto Rico for public health
control and prevention planning.
SUMMARY:
lotter on DSKBCFDHB2PROD with NOTICES
Number of
respondents
Type of respondent
CDC must receive written
comments on or before June 26, 2020.
DATES:
VerDate Sep<11>2014
17:32 Apr 24, 2020
Jkt 250001
You may submit comments,
identified by Docket No. CDC–2020–
0039 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
ADDRESSES:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
2,700,000
1
5/60
800
1
5/60
800
1
5/60
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Leptospirosis and melioidosis active
hospital-based surveillance in Puerto
Rico—New—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The project aims to identify
leptospirosis and melioidosis cases in
Puerto Rico by establishing active
surveillance for both diseases at four
hospital sites for timelier disease
identification and treatment and to
improve understanding of leptospirosis
and melioidosis epidemiology and
ecology in Puerto Rico for public health
control and prevention planning. Both
diseases can cause outbreaks after
hurricanes and flooding, especially in
tropical areas, and this project is being
conducted in response to an increase in
leptospirosis cases after Hurricanes Irma
and Maria in 2017.
Participation is voluntary.
Participants will be recruited from the
population presenting to the emergency
E:\FR\FM\27APN1.SGM
27APN1
23359
Federal Register / Vol. 85, No. 81 / Monday, April 27, 2020 / Notices
department of the four hospital sites
with febrile illness, and will be
interviewed to gather information on
symptoms, possible exposures, and
medical history, in addition to having
diagnostic samples collected to test for
leptospirosis plus or minus melioidosis
(depending on presenting symptoms).
reservoirs related to human
leptospirosis illness in Puerto Rico.
The estimated annualized burden
hours requested are 1,675. There is no
cost to respondents other than their
time.
Participants will then also be
interviewed approximately two weeks
after enrollment to determine illness
progression and outcome. Patients
testing positive for leptospirosis, if
willing, may have animals sampled
from their home or work environments,
if present, to help determine the animal
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Patient
Patient
Patient
Patient
Patient
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
...............................................
...............................................
...............................................
...............................................
...............................................
PIFA (screening) ..............................
PIFA (full form: Sections 1–4, 11) ...
Consent Form ..................................
PIFF ..................................................
Animal Household Survey ................
7,000
3,000
3,000
1,000
250
1
1
1
1
1
5/60
10/60
6/60
10/60
30/60
583
500
300
167
125
Total ...........................................
...........................................................
........................
........................
........................
1,675
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–08794 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSKBCFDHB2PROD with NOTICES
Number of
respondents
Form name
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE15–002: The CDC National Centers of
Excellence in Youth Violence
Prevention: Building the Evidence for
Community- and Policy-Level
Prevention.
VerDate Sep<11>2014
17:32 Apr 24, 2020
Jkt 250001
Date: June 17, 2020.
Time: 8:30 a.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Official, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
Georgia 30341, Telephone (404)639–
0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–08808 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Change in Reporting
Requirements for The Federal
Cigarette Labeling and Advertising Act
(FCLAA) and Comprehensive
Smokeless Tobacco Health Education
Act (CSTHEA)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces that
it is extending the March 31, 2020
deadline for submissions required under
the Federal Cigarette Labeling and
Advertising Act (FCLAA) and the
Comprehensive Smokeless Tobacco
Health Education Act (CSTHEA) for
cigarette and smokeless tobacco
products, respectively. CDC also
announces that it is extending the
deadline for ingredient reports for new
products that are due at the time of first
importation. Previous notices
announced that ingredient reports are
due annually on March 31, and/or upon
initial importation of cigarettes and/or
smokeless tobacco products. Due to the
current public health response to
COVID–19, CDC is not able to accept
any ingredient submissions and will not
be issuing Certificates of Compliance at
this time. CDC is communicating this
information to state government entities
and will re-evaluate this approach as
necessary.
SUMMARY:
E:\FR\FM\27APN1.SGM
27APN1
Agencies
[Federal Register Volume 85, Number 81 (Monday, April 27, 2020)]
[Notices]
[Pages 23358-23359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08794]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-20MR; Docket No. CDC-2020-0039]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Leptospirosis and melioidosis
active hospital-based surveillance in Puerto Rico.'' The project aims
to identify leptospirosis and melioidosis cases in Puerto Rico by
establishing active surveillance for both diseases at four hospital
sites for timelier disease identification and treatment and to improve
understanding of leptospirosis and melioidosis epidemiology and ecology
in Puerto Rico for public health control and prevention planning.
DATES: CDC must receive written comments on or before June 26, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0039 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Leptospirosis and melioidosis active hospital-based surveillance in
Puerto Rico--New--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The project aims to identify leptospirosis and melioidosis cases in
Puerto Rico by establishing active surveillance for both diseases at
four hospital sites for timelier disease identification and treatment
and to improve understanding of leptospirosis and melioidosis
epidemiology and ecology in Puerto Rico for public health control and
prevention planning. Both diseases can cause outbreaks after hurricanes
and flooding, especially in tropical areas, and this project is being
conducted in response to an increase in leptospirosis cases after
Hurricanes Irma and Maria in 2017.
Participation is voluntary. Participants will be recruited from the
population presenting to the emergency
[[Page 23359]]
department of the four hospital sites with febrile illness, and will be
interviewed to gather information on symptoms, possible exposures, and
medical history, in addition to having diagnostic samples collected to
test for leptospirosis plus or minus melioidosis (depending on
presenting symptoms). Participants will then also be interviewed
approximately two weeks after enrollment to determine illness
progression and outcome. Patients testing positive for leptospirosis,
if willing, may have animals sampled from their home or work
environments, if present, to help determine the animal reservoirs
related to human leptospirosis illness in Puerto Rico.
The estimated annualized burden hours requested are 1,675. There is
no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Patient....................... PIFA (screening) 7,000 1 5/60 583
Patient....................... PIFA (full form: 3,000 1 10/60 500
Sections 1-4,
11).
Patient....................... Consent Form.... 3,000 1 6/60 300
Patient....................... PIFF............ 1,000 1 10/60 167
Patient....................... Animal Household 250 1 30/60 125
Survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,675
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-08794 Filed 4-24-20; 8:45 am]
BILLING CODE 4163-18-P